Vanguard Group
LUMO

Vanguard Group’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Vanguard Group’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-244,082
Closed -$945K – 4339
2024
Q3 		$945K Hold
244,082
– – ﹤0.01% 3791
2024
Q2 		$566K Hold
244,082
– – ﹤0.01% 3961
2024
Q1 		$688K Hold
244,082
– – ﹤0.01% 3932
2023
Q4 		$776K Buy
244,082
+8,645
+4% +$29.4K ﹤0.01% 3903
2023
Q3 		$777K Sell
235,437
-1,531
-0.6% -$4.77K ﹤0.01% 3921
2023
Q2 		$782K Hold
236,968
– – ﹤0.01% 3974
2023
Q1 		$784K Hold
236,968
– – ﹤0.01% 3990
2022
Q4 		$855K Buy
236,968
+53
+0% +$347 ﹤0.01% 3956
2022
Q3 		$2.1M Hold
236,915
– – ﹤0.01% 3721
2022
Q2 		$1.82M Sell
236,915
-1,193
-0.5% -$9.54K ﹤0.01% 3842
2022
Q1 		$2.24M Hold
238,108
– – ﹤0.01% 3910
2021
Q4 		$1.65M Sell
238,108
-921
-0.4% -$7.74K ﹤0.01% 4112
2021
Q3 		$2.27M Buy
239,029
+1,131
+0.5% +$10.6K ﹤0.01% 4024
2021
Q2 		$2.38M Sell
237,898
-55
-0% -$612 ﹤0.01% 3920
2021
Q1 		$2.78M Buy
237,953
+10,489
+5% +$176K ﹤0.01% 3787
2020
Q4 		$8.12M Buy
227,464
+5,917
+3% +$102K ﹤0.01% 3102
2020
Q3 		$3.06M Sell
221,547
-3,844
-2% -$57.5K ﹤0.01% 3353
2020
Q2 		$3.72M Buy
225,391
+80,650
+56% +$960K ﹤0.01% 3226
2020
Q1 		$1.23M Buy
144,741
+1
+0% +$14 ﹤0.01% 3436
2019
Q4 		$3.3M Hold
144,740
– – ﹤0.01% 3306
2019
Q3 		$2.07M Sell
144,740
-12,249
-8% -$180K ﹤0.01% 3442
2019
Q2 		$2.09M Buy
156,989
+36,723
+31% +$555K ﹤0.01% 3464
2019
Q1 		$2.09M Buy
120,266
+25,019
+26% +$373K ﹤0.01% 3433
2018
Q4 		$1.3M Sell
95,247
-84,172
-47% -$1.48M ﹤0.01% 3488
2018
Q3 		$3.86M Buy
179,419
+15,216
+9% +$463K ﹤0.01% 3324
2018
Q2 		$7.03M Buy
164,203
+15,215
+10% +$697K ﹤0.01% 3070
2018
Q1 		$9.72M Buy
148,988
+3,742
+3% +$265K ﹤0.01% 2837
2017
Q4 		$10.6M Buy
145,246
+32,169
+28% +$2.66M ﹤0.01% 2791
2017
Q3 		$10.4M Buy
113,077
+10,105
+10% +$775K ﹤0.01% 2792
2017
Q2 		$6.81M Sell
102,972
-3,682
-3% -$456K ﹤0.01% 2961
2017
Q1 		$23.1M Buy
106,654
+5,668
+6% +$810K ﹤0.01% 2385
2016
Q4 		$9.34M Buy
100,986
+2,747
+3% +$310K ﹤0.01% 2781
2016
Q3 		$13.3M Buy
98,239
+2,190
+2% +$218K ﹤0.01% 2546
2016
Q2 		$9.73M Sell
96,049
-34,944
-27% -$4.33M ﹤0.01% 2663
2016
Q1 		$21.5M Sell
130,993
-12,226
-9% -$2.48M ﹤0.01% 2275
2015
Q4 		$46.9M Buy
143,219
+6,007
+4% +$1.96M ﹤0.01% 1906
2015
Q3 		$44.3M Buy
137,212
+20,142
+17% +$8.85M ﹤0.01% 1924
2015
Q2 		$46.6M Buy
117,070
+41,234
+54% +$17.5M ﹤0.01% 1979
2015
Q1 		$37.3M Buy
75,836
+5,163
+7% +$2M ﹤0.01% 2049
2014
Q4 		$25.3M Buy
70,673
+5,628
+9% +$1.68M ﹤0.01% 2154
2014
Q3 		$12.5M Buy
65,045
+4,945
+8% +$1.09M ﹤0.01% 2393
2014
Q2 		$14.4M Buy
60,100
+2,157
+4% +$439K ﹤0.01% 2353
2014
Q1 		$14.8M Buy
57,943
+6,683
+13% +$2.04M ﹤0.01% 2302
2013
Q4 		$10.2M Buy
51,260
+2,169
+4% +$386K ﹤0.01% 2455
2013
Q3 		$8.3M Buy
49,091
+4,235
+9% +$682K ﹤0.01% 2484
2013
Q2 		$7.96M Buy
+44,856
New +$6.35M ﹤0.01% 2438

Vanguard Group's LUMO Position: Q4 2024 in Review

Vanguard Group sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2024, closing a stake of 244,082 shares — an estimated $945K sold.

Vanguard Group first reported a position in LUMO in Q2 2013 and held it in 46 quarters. The position peaked at $46.9M in Q4 2015. 0 funds tracked by Wall St. Rank hold LUMO as of Q4 2024.

  • Vanguard Group reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Vanguard Group sold 244,082 Lumos Pharma, Inc. Common Stock shares in Q4 2024, an estimated $945K.
  • Vanguard Group first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 46 quarters.
  • Vanguard Group's Lumos Pharma, Inc. Common Stock position peaked at $46.9M in Q4 2015.
  • 0 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2024.

Based on Vanguard Group's 13F filing for Q4 2024, filed 11 Feb 2025.